(Q40603742)

22 September 2017

Antecedent symptoms in Guillain-Barré syndrome: an important indicator for clinical and serological subgroups (English)

1 reference

22 September 2017

Guillain–Barré syndrome

0 references

1

Koga M

1 reference

22 September 2017

2

Yuki N

1 reference

22 September 2017

Hirata K

3

1 reference

PubMed ID

11328202

22 September 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

Acta Neurologica Scandinavica

22 September 2017

1 reference

22 September 2017

103

1 reference

22 September 2017

5

1 reference

22 September 2017

278-287

1 reference

The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study

22 September 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

Campylobacter jejuni infection and Guillain-Barré syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

Guillain-Barré syndrome: multifactorial mechanisms versus defined subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

Clinical and epidemiologic features of Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

An acute axonal form of Guillain-Barré polyneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

Pathology of the motor-sensory axonal Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

Two species of antiganglioside antibodies in a patient with a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

Is IgG anti-GT1a antibody associated with pharyngeal-cervical-brachial weakness or oropharyngeal palsy in Guillain-Barré syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

ROLE OF INFECTION IN THE GUILLAIN-BARR'E SYNDROME

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

A prospective study of acute idiopathic neuropathy. II. Antecedent events

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

Guillain-Barre syndrome: a series observed at Riyadh Armed Forces Hospital January 1984--January 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

Neuropathy in the Miller Fisher syndrome: clinical and electrophysiologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

Prognostic factors of Guillain-Barré syndrome after intravenous immunoglobulin or plasma exchange. Dutch Guillain-Barré Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

Assessment of current diagnostic criteria for Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

Antiganglioside antibody in patients with Guillain-Barré syndrome who show bulbar palsy as an initial symptom

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

Pain in the Guillain-Barré syndrome: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

21 January 2018

Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

7 January 2021

Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

7 January 2021

Acute cytomegalovirus infection and IgM anti-GM2 antibody

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

7 January 2021

The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

7 January 2021

Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

7 January 2021

Frequent presence of anti-GQ1b antibody in Fisher's syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

7 January 2021

Guillain-Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain-Barré Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

7 January 2021

Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

7 January 2021

Role of infection in Guillain-Barré syndrome: laboratory confirmation of herpesviruses in 41 cases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

7 January 2021

Mycoplasma antibody in Guillain-Barré syndrome and other neurological disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

7 January 2021

Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

7 January 2021

Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

7 January 2021

Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

7 January 2021

Acute relapsing sensory neuropathy associated with IgM antibody against B-series gangliosides containing a GalNAc beta 1-4(Gal3-2 alpha NeuAc8-2 alpha NeuAc)beta 1 configuration

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

7 January 2021

Fisher's syndrome and group A streptococcal infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

7 January 2021

A case-control study of drugs and other determinants as potential causes of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2001.103005278.X

7 January 2021

10.1034/J.1600-0404.2001.103005278.X

Identifiers

DOI

1 reference

22 September 2017

1 reference

PubMed ID

11328202